Back
MiMedx Group Quote, Financials, Valuation and Earnings
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
84
MDXG
MiMedx Group
Last Price:
9.28
Seasonality Move:
15.95%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.MiMedx Group Price Quote
$9.28
MiMedx Group Key Stats
Buy
84
MiMedx Group (MDXG)
is a Buy
Day range:
$8.96 - $9.48
52-week range:
$5.47 - $9.48
Dividend yield:
0%
P/E ratio:
25.08
P/S ratio:
4.02
P/B ratio:
7.53%
Volume:
2.2M
Avg. volume:
791.8K
1-year change:
40.61%
Market cap:
$1.4B
Revenue:
$321.5M
EPS:
$0.61
How Much Does MiMedx Group Make?
-
How Much Are MiMedx Group's Sales Annually?
MDXG Revenues are $321.5M -
How Much Profit Does MiMedx Group's Make A Year?
MDXG net income is $67.4M
Is MiMedx Group Growing As A Company?
-
What Is MiMedx Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.03% -
What Is MiMedx Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.17%
MiMedx Group Stock Price Performance
-
Did MiMedx Group Stock Go Up Last Month?
MiMedx Group share price went up by 58.9% last month -
Did MDXG's Share Price Rise Over The Last Year?
MDXG share price rose by 40.61% over the past 1 year
What Is MiMedx Group 52-Week High & Low?
-
What Is MiMedx Group’s 52-Week High Share Price?
MiMedx Group has traded as high as $9.48 over the past 52 weeks -
What Is MiMedx Group’s 52-Week Low Share Price?
MiMedx Group has traded as low as $5.47 over the past 52 weeks
MiMedx Group Price To Free Cash Flow
-
Is MiMedx Group Stock Overvalued?
MiMedx Group is trading at a price to free cash flow ratio of 27.29 -
Is MiMedx Group Stock Undervalued?
MiMedx Group EV to Free Cash Flow ratio is 25.64 -
What Is MiMedx Group’s Price Earnings Growth Ratio?
MDXG PEG ratio is 0.00 -
Is MiMedx Group Trading At A Premium To Earnings?
MiMedx Group EV to EBIT ratio is 20.37
Is It Risky To Buy MiMedx Group?
-
How Much Debt Does MiMedx Group Have?
Total long term debt quarterly is $19M -
How Much Cash Does MiMedx Group Have?
Cash and short term investments quarterly total is $88.8M -
What Is MiMedx Group’s Book Value Per Share?
Book value per share is 1.23
Is MiMedx Group Cash Flow Positive?
-
What Is MDXG Cash Flow From Operations?
Cash flow from operations (TTM) is $57.7M -
What Is MiMedx Group’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$42.7M -
What Is MiMedx Group’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$7.3M
MiMedx Group Return On Invested Capital
-
Is Management Doing A Good Job?
MDXG return on invested capital is 60.77% -
What Is MiMedx Group Return On Assets?
ROA measures how assets are converting to revenues and is 43.45% -
What Is MDXG Return On Equity?
ROE is a measure of profitability and is 75.27%
MiMedx Group Earnings Date & Stock Price
-
What Is MiMedx Group's Stock Price Today?
A single share of MDXG can be purchased today for 9.28 -
What Is MiMedx Group’s Stock Symbol?
MiMedx Group trades on the nasdaq under the ticker symbol: MDXG -
When Is MiMedx Group’s Next Earnings Date?
The next quarterly earnings date for MiMedx Group is scheduled on February 28, 2025 -
When Is MDXG's next ex-dividend date?
MiMedx Group's next ex-dividend date is November 16, 2024 -
How To Buy MiMedx Group Stock?
You can buy MiMedx Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
MiMedx Group Competitors
-
Who Are MiMedx Group's Competitors?
Below is a list of companies who compete with MiMedx Group or are related in some way:
MiMedx Group Dividend Yield
-
What Is MDXG Dividend Yield?
MiMedx Group’s dividend yield currently is 0% -
What Is MiMedx Group’s Payout Ratio?
MiMedx Group’s payout ratio is 0% -
When Did MiMedx Group Last Pay A Dividend?
The latest dividend pay date is November 16, 2024 -
What Is MiMedx Group’s Dividend Per Share?
MiMedx Group pays a dividend of $0.00 per share
MiMedx Group Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -16.67% | 55.56% |
| Revenue: | 2.87% | 1.25% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 12.60 |
| Upside from Last Price: | 35.78% |